Cancer Vaccine Institute News

CVI Director Dr. Nora Disis spoke with Karina Vargas from KOMO4 news about the findings of our Phase I clinical trial with a HER2 ICD DNA...

We're excited to see the findings from our recent publication in JAMA Oncology describing our Phase I clinical trial with the HER2 ICD...

Check out CVI's Dr. Nora Disis' interview with KUOW NPR on the exciting prospects of cancer vaccines for therapy, cancer interception and...

Dr. Nora Disis, CVI Director, and Dr. Nicole Kretzer, Clinical Acting Instructor, spoke this past Friday, October 14th as part of...

Dr. Nora Disis (CVI Director) was featured in a New York Times article this week. Dr. Disis shares the promise of our STEMVAC vaccine for...